Filter
39
Featured
Language
Document type
Studies & Reports
37
Manuals
1
Guidelines
1
Countries / Regions
Africa
5
Bangladesh
2
North Macedonia
1
Tajikistan
1
Nepal
1
Thailand
1
Serbia
1
Ghana
1
Kazakhstan
1
Nigeria
1
Kyrgyzstan
1
Uzbekistan
1
Malawi
1
Armenia
1
Tanzania
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Western and Central Europe
1
Russia
1
Georgia
1
India
1
Authors & Publishers
World Health Organization WHO
5
et al.
4
Craig, J.
2
A. Sriram
1
A.B. A. Boxall, D. W. Kolpin, et al.
1
Aboud S., R. Mdegela
1
AOSIS
1
Apisarnthanarak A.,S. Danchaivijitr,T. Khawcharoenporn, et al.
1
Asaduzzaman, M. et al.
1
Beovic B., M. Dousak, C. Pulcini et al.
1
Berman, D.
1
BMC Biology
1
BMC Infectious Diseases
1
Bortone, B.
1
Boston Consulting Group
1
D. Gyamfi Amoako, R. Carrel Founou, et al.
1
Dacombe R., I. Bates, B. Gopul et al.
1
Doyle, M.P.
1
Emmanuel O. Irek, Adewale A. Amupitan, Temitope O. Obadare, Aaron O. Aboderin
1
Essack S.Y., A.T. Desta, R.E. Abotsi et al.
1
European Centers for Disease Control and Prevention ECDC
1
European Centre for Disease Prevention and Control ECDC
1
European Public Health Alliance
1
Founou, L.L.
1
G. H. Loneragan, H. M. Scott et al.
1
Gajda M., E. Urban
1
Global Antibiotic Resistance Partnership—Tanzania Working Group
1
Goff, D.
1
Hindawi
1
Hsia Y., B. R Lee, A. Versporten, et al
1
I. Frost
1
Joshi, M.P.
1
Journal of Public Health
1
K. Hiban, I. Frost, et al.
1
K.L Tang, N.P Caffrey, D.B Nóbrega, et al.
1
Kakkar M., Chatterjee P. et. al.
1
Kariuki S., K. H. Keddy, M. Antonio
1
Liverpool School of Tropical Medicine
1
Murni I. K., T. Duke, S. Kinney et al.
1
Oxford University Press
1
P. Collignon, J.J.Beggs, T.R. Walsh, et al.
1
Pan American Health Organization PAHO, World Health Organization WHO
1
Public Health Foundation India
1
ReAct Action on Antibiotic Resistance
1
Rousham E. K., M. Aminul Islam, P. Nahar et al.
1
The Lancet
1
Tilahun Tadesse, B., E. A. Ashley, S. Ongarello et al.
1
UN Environment
1
Wellcome Trust
1
Wilkinson, J.L.
1
World Health Organization WHO
1
Wright G.D.
1
Yohaness Garoy E., Y. Berhane Gebreab, O. Okoth Achila et al.
1
Publication Years
Category
Drugs & Medical Equipment
2
Studies & Reports
2
Toolboxes
Studies
38
Antimicrobial Resistance (AMR)
4
Country specific
3
General
3
Best Practice
2
Water Pollution
2
Research & Development
1
Clinical Guidelines
1
Global Impact: Socio-economic, health services, TB & HIV
1
Pharmaceutical Assessments
1
Reports & Studies
1
Assessment
1
The Lancet Planetary Health, Volume 2, ISSUE 9, Pe398-e405, September 01, 2018. Reduction of antibiotic consumption will not be sufficient to control antimicrobial resistance because contagion—the spread of resistant strains and resistance genes—seems to be the dominant contributing factor. Im... more
MICROBIAL DRUG RESISTANCEVolume 24, Number 5, 2018ªMary Ann Liebert, Inc.DOI: 10.1089/mdr.2017.0383 Antibiotic resistance (ABR) is a worldwide publichealth concern, with serious health, economic, and so-cietal repercussions. Its emergence is attributed to the se-lective pressure exerted by antib... more
Comprehensive Reviews in Food Science and Food Safety, Vol.12 (2013) pp.234-248 In 2006, the Institute of Food Technologists (IFT) published an Expert Report entitled “Antimicrobial Resistance: Implications for the Food System” (IFT 2006). That report summarized current scientific knowledge pe... more
The escalating antimicrobial resistance (AMR) pandemic is a global public health threat with extensive health, economic and societal implications. Resistance emerges because of selection pressure from rational and indiscriminate antimicrobial use in human health as well as in the veterinary, agricul... more
Since the World Health Organization (WHO) launched the Global Antimicrobial Resistance Surveillance System (GLASS) in 2015, there has been rapidly growing awareness among many African countries that they need to be doing more to combat antimicrobial resistance (AMR). The Africa Centres fo... more
Internationally, there is a growing concern over antimicro-bial resistance (AMR) which is currently estimated to ac-count for more than 700,000 deaths per year worldwide. If no appropriate measures are taken to halt its pro-gress, AMR will cost approximately 10 million lives andabout US$100 trillion... more
Overuse of antimicrobial agents occurs globally in both community and hospital settings. Misuse of antibiotics can lead to a variety of adverse outcomes, including the development of antimicrobial resistanceand increased cost of hospitalization. This issuehas been particularly problematic in de... more
Methicillin-resistant Staphylococcus aureus(MRSA) strainsor multidrug-resistant S.aureus, initially described in 1960s,emerged in the last decade as a cause of nosocomial infections responsible for rapidly progressive, potential fatal diseases including life-threatening pneumonia, necrotizing fascii... more
This study addresses part of the Terms of Reference for a scoping report ‘An analysis of approaches to laboratory capacity strengthening for drug resistant infections in low and middle income countries’. It has been produced as a separate report because it is also very relevant for a second stud... more
The ECDC, the EFSA and the EMA have for the first time jointly explored associations between consumption of antimicrobials in humans and food-producing animals, and antimicrobial resistance in bacteria from humans and food-producing animals, using 2011 and 2012 data currently available from their re... more
Global actions to reduce antimicrobial resistance (AMR) include optimising the use of antimicrobial medicines in human and animal health. In countries with weak healthcare regulation, this requires a greater understanding of the drivers of antibiotic use from the perspective of providers and consume... more
Historically, the discovery of the sulfa drugs in the 1930s and the subsequent development of penicillin during World War II ushered in a new era in the treatment of infectious diseases. Infections that were common causes of death and disease in the pre-... more
Nosocomial infections, or hospital-acquired infec-tions (HAI), are among the most significant causesof morbidity and mortality in healthcare settingsthroughout the world.Prevention of HAIs iscentral to providing high quality and safe health-care, even in settings with limited resources.Transmi... more

Situation Analysis and Recommendation: Antibiotic Use and Resistance in Tanzania

Aboud S., R. Mdegela Global Antibiotic Resistance Partnership—Tanzania Working Group (2015) C2
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe infections are potentially curable as long as the aetiological agents are susceptible to the ... more
WHO would like to express its gratitude and appreciation to all Member States that provided information to the WHO survey on policies and activities at the national level in the area of antimicrobial resistance. The contribution of staff in WHO Regional and Country Offices has been invaluable: in ga... more
In this edition, the Antimicrobial Resistance chapter discusses the growing, dangerous trend of antimicrobial resistance and the potential catastrophic consequences on global health. Chapter 1 of Frontier 2017: Emerging Issues of Environmental Concern
Antimicrobial resistance (AMR) has emerged as a major public health concern, around which the international leadership has come together to form strategic partnerships and action plans. The main driving force behind the emergence of AMR is selection pressure created due to consumption of antibiotics... more